FDA Approves Emergency Use of Remdesivir for COVID-19
SATURDAY, May 2, 2020 — As the U.S. coronavirus death toll neared 65,000 on Friday, the U.S. Food and Drug Administration approved emergency use of the first drug that seems to boost recovery among COVID-19 patients. Remdesivir, Gilead Sciences’ intravenous antiviral medication, is to be used for hospitalized patients with “severe disease,” such as those… Read More »